Professor Adrian Harris
Oxford University Hospitals NHS Trust
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Professor Adrian Harris as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01668550 · A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid TumoursCancer Research UK · terminated · Advanced Solid Tumours · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 35 PubMed records, and a shared surname and initials can bring in a namesake. All 35 on PubMed
- Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome.Circulation · 2005133 citationsRCR 4.0
- 124 citationsRCR 3.8
- Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.Clin Cancer Res · 2001119 citationsRCR 2.9
- Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.Pharmacol Res Perspect · 2017119 citationsRCR 3.8
- Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.J Clin Oncol · 2004105 citationsRCR 2.5
- Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I study.Clin Cancer Res · 2008105 citationsRCR 2.5
- Water ingestion as prophylaxis against syncope.Circulation · 200384 citationsRCR 2.7
- Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.J Clin Oncol · 200783 citationsRCR 1.9
- Effect of dietary restriction on body condition, composition and welfare of overweight and obese pony mares.Equine Vet J · 201072 citationsRCR 3.1
- The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.Clin Pharmacol Ther · 200168 citationsRCR 1.9